E6-p53 inhibitors (Priaxon)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug NameE6-p53 inhibitors (Priaxon)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTumor protein p53 inhibitors

TargetsTumor protein p53

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPriaxon Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPriaxon Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A